Nociception

Nociception is the sensory process that provides the signals that lead to pain. This occurs through nociceptors, primary sensory neurons that are activated by stimuli that cause tissue damage. Stimuli can include tissue injury, extremes of heat and noxious chemicals. Unlike other sensory neurons that detect vision or taste, nociceptors are located all around the body, particularly under the skin, however, they are notably absent from the brain.

Nociception Products Targets

Products for Nociception - Page 17

  1. Cat.No. Product Name Information/Activity
  2. BCC7847 Sipatrigine Sipatrigine, a neuroprotective agent, is a glutamate release inhibitor, voltage-dependent sodium channel and calcium channel inhibitor, penetrating the central nervous system. Has potential to treat focal cerebral ischemia and stroke. Sipatrigine chemical structure
  3. BCC6179 TC-N 1752 1211866-85-1 TC-N 1752 chemical structure
  4. BCN1035 Tetrodotoxin Tetrodotoxin is a highly selective <b>sodium channel</b> blocker, with <b>IC<sub>50</sub></b> of 33 nM for <b>Nav1.6</b>. Tetrodotoxin chemical structure
  5. BCC2156 Valproic acid sodium salt (Sodium valproate) Valproic acid sodium salt (Sodium Valproate) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium salt activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches. Valproic acid sodium salt (Sodium valproate) chemical structure
  6. BCN2609 Vinpocetine Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders. Vinpocetine chemical structure
  7. BCC1048 β-Pompilidotoxin Slows neuronal Na<sup>+</sup> channel inactivation β-Pompilidotoxin chemical structure
  8. BCC5078 Rufinamide Rufinamide(E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS). Rufinamide chemical structure
  9. BCC7928 BIMU 8 Potent 5-HT<sub>4</sub> receptor full agonist BIMU 8 chemical structure
  10. BCC4207 Cisapride 81098-60-4 Cisapride chemical structure
  11. BCC7562 CJ 033466 519148-48-2 CJ 033466 chemical structure

Items 161 to 170 of 957 total